Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Comment by foundalphaon Oct 23, 2023 10:19pm
89 Views
Post# 35697487

RE:RE:RE:News

RE:RE:RE:NewsNegative vibes, eh??? I seem to recall saying a few days ago I predicted a 50% dilution or AION filing for protection. I'll admit I got lucky guessing the dilution percentage, but it wasn't luck guessing one of the two outcomes. Nice press release. Shareholders just suffered a 47% dilution to acquire a money-losing operation in a completely different sector. AION was insolvent and had been insolvent for at least two years. They had to do something, so this change of control/new business is not a surprise. The upside is the acquiror business seems to be growing revenues, so it can generate cashflow in the immediate term. I guess the market never saw the value in the 'patents on cancer curing medicine' you referred to.

<< Previous
Bullboard Posts
Next >>